Epidemiology and Management of Metastatic Breast Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.
Condition or disease
Breast Cancer Nos Metastatic Recurrent
Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study
The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage [ Time Frame: At 12 and 18 months after diagnosis ]
Secondary Outcome Measures :
The progression free survival (PFS) rates [ Time Frame: At 12 and 18 months after diagnosis ]
The progression free survival (PFS) time [ Time Frame: At 18 months after diagnosis ]
Time to progression (TTP) [ Time Frame: At 18 months after diagnosis ]
The clinical and pathological characteristics of newly diagnosed MBC patients [ Time Frame: At 18 months after diagnosis ]
The socio-demographic and anthropometric characteristics of newly diagnosed MBC patients [ Time Frame: At 18 months after diagnosis ]
Health care utilization associated with the disease in Romania [ Time Frame: At 18 months after diagnosis ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Female patients diagosed with metastatic breast cance, age > 18 years
Female aged 18 years and over Diagnosis of breast cancer according to ICD-10 diagnostic criteria with confirmed metastasis
Confirmed diagnosis between 1st July 2010 - 30th June 2011
Female patient managed for her disease at the same setting where final diagnosis of MBC was performed
History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer)